TPG-Axon Capital logo

TPG-Axon Capital

North America, New York, United States, New York

Description

TPG-Axon Capital is a global investment firm focused on short and long term investing across all geographies.

Investor Profile

TPG-Axon Capital has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Private Equity (25%)
  • Series E (25%)
  • Series Unknown (25%)
  • Convertible Note (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Communications Infrastructure
  • Mobile
  • Wireless
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does TPG-Axon Capital frequently co-invest with?

WI
North America, Wisconsin, United States, Oshkosh
Co-Investments: 2
Credit Suisse
North America, North Carolina, United States, Morrisville
Co-Investments: 1
CV
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Prime Movers Lab
North America, Wyoming, United States, Jackson
Co-Investments: 1
Deerfield
North America, New York, United States, New York
Co-Investments: 1
Jennison Associates
North America, New York, United States, New York
Co-Investments: 2
I Squared Capital
North America, Florida, United States, Miami
Co-Investments: 1
SD
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by TPG-Axon Capital?

Tarana Wireless

Milpitas, California, United States

Tarana Wireless provides wireless performance in small-cell backhaul, fiber extension, and residential broadband.

Communications InfrastructureMobileWireless
Series UnknownMar 23, 2022
Amount Raised: $170,000,000
Singular Genomics

La Jolla, California, United States

Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine.

BiotechnologyHealth CareMedical
Convertible NoteMay 12, 2021
Amount Raised: $130,500,000
Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Private EquityApr 14, 2011
Amount Raised: $77,000,000
Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series EApr 3, 2006
Amount Raised: $65,000,000